Format

Send to

Choose Destination
Nurse Pract. 2017 Dec 15;42 Suppl 12:3-9. doi: 10.1097/01.NPR.0000526627.04268.80.

Managing hypertriglyceridemia: What can we learn from cardiovascular outcomes trials?

Author information

1
Tina Copple is a Senior Nurse Practitioner at the Diabetes & Glandular Disease Clinic, San Antonio, Tex. Nicole A. Ciffone is an Adult Nurse Practitioner, Clinical Lipid Specialist, and Founder of the Arizona Center for Advanced Lipidology, Tucson, Ariz.

Abstract

Cardiovascular (CV) risk remains in some patients who are treated with statins. Evidence supports a role for triglycerides (TGs) in CV disease. TG-lowering agent outcomes studies have been inconsistent, but eicosapentaenoic acid significantly reduced coronary events in hypercholesterolemic patients who were treated with statins. Ongoing outcomes studies will clarify the role of TG-lowering treatments in CV risk reduction.

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center